Back to All Collaborations

GSK – The University of Dundee collaborations on Neglected Tropical Diseases (NTDs) treatments

Active Since: 2011-2022

Contributing to SDGs…

Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.

MEMBER COMPANIES

PARTNER ORGANISATIONS

  • Academia or research institute

    University of Dundee

  • Global NGOs

    Wellcome Trust

Objectives

  • Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.

GSK and the Drug Discovery Unit (DDU) at the University of Dundee have a long-standing partnership to research Neglected Tropical Diseases (NTDs). In April 2017, the Wellcome Trust awarded the University of Dundee £7.9m for a joint five-project with GSK to boost efforts to find new drugs to treat some of the world’s most devastating parasitic diseases – visceral and cutaneous leishmaniasis, and Chagas’ disease.

Quote
"The collaboration with the University of Dundee and this funding from Wellcome are vital boosts towards the achievement of GSK’s goal of producing new preclinical candidates for leishmaniasis and/or Chagas’ disease."
 Dr Jose Fiandor
Director of GSK’s Kinetoplastids Discovery Performance Unit

SDGs THE PARTNERSHIP CONTRIBUTES TO

RESULTS & MILESTONES

Major highlights in results to date include reaching:

  • Candidate Selection for GSK3186899 for Visceral Leishmaniasis in 2016
  • Candidate Selection for GSK3494245 for Visceral Leishmaniasis in 2016
  • Commit to First time in Human for GSK3186899 for Visceral Leishmaniasis in 2019

ADDITIONAL INFORMATION

Geographic Reach

Global Commitment

Disease Area

Neglected Tropical Diseases (NTDs)

  • Chagas Disease
  • Other